Danaher raises quarterly dividend by 25% to $0.40/share
Danaher (DHR) declares $0.40/share quarterly dividend, 25% increase from prior dividend of $0.32. Forward yield...
Tag: DHR
Biggest stock movers Tuesday: ZIM, CMPS, and more
Stock futures dipped Tuesday morning amid a holiday-shortened trading week, spotlighting key economic data and corporate...
Danaher nears $10B acquisition of medical tech company Masimo, FT reports
Danaher (DHR) is nearing a roughly $10 billion deal to acquire U.S. medical technology firm Masimo (MASI), the Financial...
Danaher outlines 3%-6% core revenue growth and $8.35-$8.50 EPS guidance for 2026 amid bioprocessing strength
Earnings Call Insights: Danaher Corporation (DHR) Q4 2025 Rainer Blair, President, CEO & Director, reported "a strong...
Danaher drops after in-line earnings outlook
Danaher (DHR) shares slipped ~5% in the premarket on Wednesday after the life sciences company failed to impress Wall Street...
Danaher Non-GAAP EPS of $2.23 beats by $0.04, revenue of $6.84B beats by $30M
Danaher press release (DHR): Q4 Non-GAAP EPS of $2.23 beats by $0.04. Revenue of $6.84B (+5.2% Y/Y) beats by $30M....
Danaher Q4 2025 Earnings Preview
Danaher (DHR) is scheduled to announce Q4 earnings results on Wednesday, January 28th, before market open. The consensus...
Agilent, Danaher could be potential buyers of Qiagen – analyst
Agilent Technologies (A) and Danaher (DHR) screen as potential buyers of Qiagen (QGEN) after a report that the European...
Federal appeals court rejects NIH research funding cuts
A U.S. appeals court has ruled against the Trump administration’s moves to implement drastic cuts to federal grant funding...